Philips and Japan Lifeline: New Partnership for Lead Management Products
In a significant move for the healthcare technology sector in Japan,
Philips Japan has recently finalized an exclusive sales agreement with
Japan Lifeline, covering lead management products. This partnership is poised to elevate patient care standards by leveraging each company’s strengths.
The Agreement Details
The two companies reached a basic agreement on December 25, 2024, which paved the way for this exclusive sales contract. As per this arrangement, Japan Lifeline has obtained exclusive rights to sell designated lead management products. The sales activities are set to commence on May 1, 2025, and will continue for a period of three years.
This collaboration is expected to combine Philips' extensive expertise in lead management with Japan Lifeline's robust sales network in the CRM (Cardiac Rhythm Management) sector, driving the growth of both organizations over the medium term. The ultimate goal is to provide enhanced treatment options for patients in need.
Featured Lead Management Products
As part of this agreement, several key lead management products will be marketed:
- - Eximer Laser Intra-cardiac Lead Extraction System
Medical Device Approval Number: 22000BZX00968000
Highly managed medical device.
- - Lead Locking Device Kit
Medical Device Approval Number: 22300BZX00190000
Highly managed medical device.
- - Bridge Occlusion Balloon Catheter
Medical Device Approval Number: 23000BZI00035000
Highly managed medical device.
These technologies are crucial for advancing cardiac care, notably in lead extraction and management, which is a vital component in the treatment and monitoring of patients with cardiac conditions.
About Philips Japan
Philips Japan, established in 1953, operates as the Japanese subsidiary of
Royal Philips. The company focuses on developing and providing innovative healthcare technology solutions, striving to achieve better health outcomes and fulfilling lives for individuals. Philips Japan spans various healthcare areas including imaging diagnostics, ultrasound diagnostics, image-guided therapy, vital signs monitoring, health informatics, and personal health products like electric shavers and toothbrushes.
With a workforce of approximately 2,000 employees across around 70 locations, Philips Japan is dedicated to addressing the challenges posed by Japan's rapidly aging population. The company actively participates in contributing to better healthcare and improved living standards throughout the country. You can explore more about Philips Japan through their official website
here.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHI) is a leading health technology company with a mission to enhance people’s health and well-being through innovative technology. The organization designs solutions centered around people, integrating advanced technologies with insights from healthcare professionals and consumers alike. With a global presence spanning over 100 countries, Philips generates revenue of approximately €18 billion in 2024, employing around 69,700 people worldwide.
Philips leads in various fields including imaging diagnostics, ultrasound diagnostics, image-guided therapies, biosensing, and personal health. For the latest news about Philips, visit their
news center.
As this partnership unfolds, both Philips and Japan Lifeline aim to ensure that more patients receive the appropriate treatments, marking a major step forward in cardiac care in Japan.